Merck Should Have Pulled Vioxx in 2000 -Study
28228
US drugs giant Merck &amp; Co Inc. should have pulled its Vioxx painkiller from the market four years ago, because data showing it raised the risk of heart attacks has existed since 2000, Swiss scientists said on Friday.
361813
The Wall Street Journal has reported that pharmaceutical company Merck knew as far back as 2000 that its arthritis medication, Vioxx, was linked to an increased risk of heart attack.
497670
Oct. 11 issue - Last week Merck pulled its blockbuster arthritis-and-pain-relief drug Vioxx from the market. This week the 1.27 million Americans who were taking it are wondering what to do.
90172
Merck Labs has pulled Vioxx, their arthritis drug, off the market after discovering during trials the possibility of a link to stroke or heart attack.
628834
Merck & Co Inc. on Thursday pulled its  arthritis drug Vioxx off the market after a study showed it  doubled the risk of heart attack and stroke, a move that sent  its shares plunging and erased $25 billion from its market  value.
646131
U.S. drugs giant Merck & Co Inc. should have pulled its Vioxx painkiller from the market four years ago because data showing it raised the risk of heart attacks has existed since 2000, Swiss scientists said on Friday.
33474
On September 30, 2004, Merck &amp; Co. announced the immediate recall of one of its COX-2 inhibitors, the anti-inflammatory drug VIOXXÂ®, because, in Merck&#39;s own words, a study it had been conducting showed that:
734594
In a move that sends millions of people searching for new relief, Merck yesterday recalled its best-selling Vioxx painkiller after a study showed the drug doubled the risk of a heart attack or stroke.
716091
NEW YORK -- Merck &amp; Co.'s board said yesterday that a 20-month investigation funded by the pharmaceutical company found senior management acted responsibly in their development and marketing of the now withdrawn pain reliever Vioxx.
627061
A PAINKILLER for arthritis sufferers should have been banned four years ago, experts said yesterday. Vioxx, used by 400,000 Brits, was taken off the market by its US makers last month due to potentially deadly side-effects.
424010
Merck said that it would stop selling Vioxx because a study found that it doubled patients' risk of heart attack and strokes.
140168
Merck &amp; Co Inc. on Thursday pulled its arthritis drug Vioxx off the market because it increases the risk of heart attack and stroke, a move that sent the company&#39;s
531829
Merck said that it would stop selling Vioxx, because a study found that it doubled patients' risk of heart attack and strokes.
80277
The arthritis drug Vioxx, used by  millions of people around the world, is being pulled off the  market after a study confirmed long-standing concerns that it  raises the risk of heart attack and stroke, the manufacturer,  Merck & Co. MRK.N, said on Thursday.
133867
The arthritis drug Vioxx, used by millions of people around the world, is being pulled off the market after a study confirmed long-standing concerns that it raises
206148
Merck reduced its 2004 forecast by 50 cents to 55 cents because of lost revenues. The move followed the recall of Vioxx from the global market on September 30th, due to its association with increased risk of heart attacks.
292877
Scientific evidence of increased heart attack risk associated with popular arthritis drug Vioxx was available as early as 2000, say Swiss scientists, although the drug was only withdrawn in September 2004.